Tanxiu Chen

Tanxiu Chen

Auto-generated profile, based on publicly available information

Tanxiu Chen


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
LWLingzhi Wang
Lingzhi Wang
WYWei Yan
Wei Yan
LXLi Xukun
Li Xukun
ZLZhihua Liu
Zhihua Liu
TTTian Tian
Tian Tian
ZCZhumei Cui
Zhumei Cui
Background: Ovarian cancer is the leading cause of gynecological cancer-related mortality. The novel oncogene S100A10 has been reported to be involved in cancer cell proliferation, invasion and metastasis. The role of S100A10 in ovarian cancer has not been well studied and the effect of S100A10 on chemotherapy remains unclear. The aims of the present study were to investigate the functional role of S100A10 in the progression and carboplatin sensitivity of ovarian cancer. Methods: We examined the expression levels in tissues of S100A10 in 138 cases of ovarian cancer by IHC. To determine the functional roles of downregulated S100A10 in ovarian cancer, cell proliferation, colony formation, cell migration and invasion assays were performed. Chemoresistance was analyzed by apoptosis assay. A xenograft tumor model was established to confirm the role of S100A10 in carboplatin resistance in vivo. Using Western blot assays, we also explored the possible mechanisms of S100A10 in ovarian cancer. Results: The results showed that increased expression of S100A10 was positively associated with carboplatin resistance (P < 0.001), tumor grade (P = 0.048) and a poorer prognosis (P = 0.0053). Functional analyses demonstrated that S100A10 suppression significantly suppressed ovarian cancer cell proliferation, colony formation, cell migration and invasion, remarkably increased carboplatin-induced apoptosis in SKOV3 and A2780 cells and inhibited tumor growth in vivo. Downregulation of S100A10 expression could inhibit cell proliferation and enhance ovarian cancer cell sensitivity to carboplatin, possibly involving the regulation of cleaved-Caspase3 and cleaved-PARP. Conclusions: Together, the results of the present study reveal that S100A10 expression can be used as a predictive marker for the prognosis of ovarian cancer and chemosensitivity to carboplatin.

1 March 2024 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
WYWei Yan
Wei Yan
HFHui Fu
Hui Fu
HLHuiqun Liu
Huiqun Liu
ZLZhentian Liu
Zhentian Liu
XQXueliang Qi
Xueliang Qi
TCTanxiu Chen
Tanxiu Chen
Background: Metastasis in penile corpus cavernosum from adenocarcinoma of lung is a rare but fatal disease, which was reported in cases without series studies. It causes various clinical symptoms seriously affecting the quality of life.Case presentation: A 72-year-old male smoker patient, who had a history of adenocarcinoma of lung after targeted therapy 36 months before, was admitted to Jiangxi Cancer Hospital because of presenting with aggressive dysuria and penis pain for one hour. A Foley catheter was inserted into the patient’s bladder with difficulty. Immediately do a bladder puncture. Emergency pelvic computed tomography (CT): a soft tissue nodule of 1.1 cm×1.4 cm was found in the cavernous area of the middle part of the penis, and the proximal urethra was dilated with a wide diameter of about 1.5 cm. The diagnosis of metastatic lung adenocarcinoma from the primary was made by CT-guided biopsy.Conclusion: The penis may be a site of metastasis from primary lung cancer, especially for old patient. Metastasis to the penis usually indicates that the primary lung cancer is at an advanced stage and the prognosis is very poor. More research is necessary to understand the underlying mechanism of adenocarcinoma of lung metastasis.

1 January 2025 in Women's Health Reports
Verified
Journal Article
Open access
LJLi Jianglong
Li Jianglong
XJXiao Jiabiao
Xiao Jiabiao
LZLiu Zhentian
Liu Zhentian
WYWang Yaqi
Wang Yaqi
YWYan Wei
Yan Wei
CTChen Tanxiu
Chen Tanxiu
Background: Emphysema has been linked to an elevated risk of lung cancer, yet the association between emphysema and breast cancer (BC) has not been established. Hence, our study aimed to investigate the potential correlation between emphysema as an exposure factor and BC as the outcome, while accounting for various covariates associated with BC. Methods: Participants from the National Health and Nutrition Examination Survey database from 1998 to 2016 were selected for analysis. Initially, ineligible individuals were excluded from this analysis. Subsequently, chi-square test and t -test were independently executed to assess variances in covariates and exposure factors between patients with BC and controls, leading to the development of a baseline table. Subsequently, weighted multivariate logistic regression analysis was conducted to explore the potential association between emphysema and BC, resulting in the development of three logistic regression models. Additionally, risk stratification analysis using weighted stratified logistic regression was performed to analyze the impact of emphysema on BC across different populations. Results: After excluding ineligible individuals, 4,937 participants remained, comprising 152 patients with BC and 4,785 controls. The baseline table revealed significant differences between BC and control samples in terms of emphysema ( p = 1 × 10 −2 ), age ( p = 5 × 10 −4 ), race ( p = 1 × 10 −3 ), marital status ( p = 5 × 10 −4 ), hypertension ( p = 5 × 10 −4 ), and number of pregnancies ( p = 2.1 × 10 −2 ). Furthermore, all p values for emphysema across the three model types were less than 0.05, indicating that the association between emphysema and BC was not significantly affected by other covariates. Meanwhile, the risk stratification analysis demonstrated that emphysema may be a risk factor for BC (odds ratio = 2.6, 95% confidence interval 1.25–5.41, p = 1.09 × 10 −2 ). Conclusion: The study’s findings indicating a correlation between emphysema and BC, with emphysema may be a risk factor for BC. This provides a potential theoretical basis for the development of BC treatment strategies.

2 December 2025 in Experimental Cell Research
Verified
Journal Article
Open access
WYWei Yan
Wei Yan
PXPengfei Xu
Pengfei Xu
DXDan Xiao
Dan Xiao
DHDong Hong
Dong Hong
HLHuiqun Liu
Huiqun Liu
ALAn-wen Liu
An-wen Liu
SLBP is significantly overexpressed in lung adenocarcinoma (LUAD) and correlates strongly with poor patient prognosis. Functional studies demonstrated that SLBP potently enhances proliferation, invasion, and metastasis of LUAD cells both in vitro and in vivo. Mechanistically, SLBP suppresses ferroptosis-a form of regulated cell death-by modulating key biochemical markers, including GSH, MDA, and Fe2+ levels, and it restores cell viability upon treatment with ferroptosis inducers. RNA-seq and biochemical analyses revealed that SLBP transcriptionally upregulates and stabilizes SLC7A11, a critical ferroptosis suppressor, thereby inhibiting lipid peroxidation and ferroptotic cell death. Additionally, immunopurification and mass spectrometry (IP-MS) identified FADS2 as a novel SLBP-interacting partner. SLBP binds to FADS2, promotes its expression, and drives metabolic reprogramming toward glutamine dependency, significantly altering choline and metal ion metabolism. This metabolic shift enhances cellular proliferation under nutrient stress. Crucially, SLBP-mediated proliferation was shown to be functionally dependent on FADS2, as FADS2 inhibition abrogates SLBP-driven growth without affecting SLBP levels. Collectively, these results uncover SLBP as a multifunctional oncoprotein that promotes LUAD progression through dual mechanisms: inhibiting ferroptosis via SLC7A11 and rewiring glutamine metabolism through FADS2, offering new potential targets for therapeutic intervention.